| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 10/17/2001 | EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 10/17/2001 | EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers |
| 10/17/2001 | CN1317490A Novel-6-sulfamine-3-quinolyl phosphonate compounds, its prepn. process and medical compsn. contg. them |
| 10/17/2001 | CN1317310A Method of preparing solid state creatine dosage and creatine dosage by same |
| 10/16/2001 | US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative |
| 10/16/2001 | US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 10/16/2001 | US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
| 10/11/2001 | WO2001074896A1 Human polynucleotides, polypeptides, and antibodies |
| 10/11/2001 | WO2001074848A2 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 10/11/2001 | WO2001074839A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 10/11/2001 | WO2001074807A1 Indolylpyrrole derivatives and cell death inhibitors |
| 10/11/2001 | WO2001074779A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 10/11/2001 | WO2001074763A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | WO2001025269A3 Human g-protein coupled receptor |
| 10/11/2001 | WO2001007470A3 Human nervous system-associated proteins |
| 10/11/2001 | DE10017102A1 Verfahren zur Herstellung von festen Kreatin-Dosierungsformen und dadurch erhältliche Dosierungsformen A process for producing solid creatine dosage forms and dosage forms obtainable thereby |
| 10/11/2001 | DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate |
| 10/11/2001 | CA2405484A1 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 10/11/2001 | CA2404545A1 Aryl and heteroaryl sulfonates |
| 10/11/2001 | CA2404074A1 Human polynucleotides, polypeptides, and antibodies |
| 10/11/2001 | CA2403991A1 Aminopyridines and their use as anticonvulsants and sodium channel blockers |
| 10/11/2001 | CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 10/10/2001 | EP1142890A1 Aminopyrazole derivatives |
| 10/10/2001 | EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 10/10/2001 | EP1142571A1 Method to produce solid creatine dosage forms and dosage forms thus obtained |
| 10/10/2001 | EP1141728A1 Kidney disease detection and treatment |
| 10/10/2001 | EP1141332A1 Human cyclic nucleotide pdes |
| 10/10/2001 | EP1141288A2 Lymphocytic membrane proteins |
| 10/10/2001 | EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy |
| 10/10/2001 | EP1141241A2 Astrocytes, their preparation and uses thereof |
| 10/10/2001 | EP1141240A1 Use of cd40 engagement to alter t cell receptor usage |
| 10/10/2001 | EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 10/10/2001 | EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/10/2001 | EP1141015A1 Insulin-like growth factor (igf) i mutant variants |
| 10/10/2001 | EP1140959A1 Inositol-containing hexasaccharides, their synthesis and their uses |
| 10/10/2001 | EP1140931A1 5ht1 antagonists for antidepressant therapy |
| 10/10/2001 | EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors |
| 10/10/2001 | EP1140861A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 10/10/2001 | EP1140836A1 Amide compounds |
| 10/10/2001 | EP1140825A1 Melatonin derivatives and medicine containing same |
| 10/10/2001 | EP1140784A2 Ion channel modulating agents |
| 10/10/2001 | EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 10/10/2001 | EP1140118A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
| 10/10/2001 | EP1140113A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 10/10/2001 | EP1140112A1 Use of etherlysophospholipids as antiinflammatory agents |
| 10/10/2001 | EP1140092A2 Method of treating sexual disturbances |
| 10/10/2001 | EP1140083A1 Novel compounds |
| 10/10/2001 | EP1140076A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome |
| 10/10/2001 | EP1140065A1 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease |
| 10/10/2001 | EP1140021A1 Improved formulation for topical non-invasive application in vivo |
| 10/10/2001 | EP1139913A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 10/10/2001 | CN1316991A Azetidine derivatives, preparation and medicines containing them |
| 10/10/2001 | CN1316906A Stable liquid formulations of botulinum toxin |
| 10/10/2001 | CN1316902A Therapeutic compositions (II) |
| 10/10/2001 | CN1316432A Cell death inhibitory albumen |
| 10/10/2001 | CN1316245A Application of tea polyphenol and its oxide in treating muscular disease |
| 10/10/2001 | CN1072494C Medicinal liquor for treatment of osteoproliferation, muscular dystrophy and rheumatism |
| 10/09/2001 | US6300365 Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
| 10/09/2001 | US6300334 Thieno[2,3-d]pyrimidine-2,4-diones |
| 10/09/2001 | US6300329 Heterocyclic pyrido(1,2-a)pyrazine compounds for treatment of parkinson's disease |
| 10/06/2001 | CA2343259A1 A process for producing solid creatine dosage forms and dosage forms obtainable thereby |
| 10/04/2001 | WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | WO2001072977A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 10/04/2001 | WO2001072960A2 Il-8 receptor antagonists |
| 10/04/2001 | WO2001072836A2 G-protein coupled receptors |
| 10/04/2001 | WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 10/04/2001 | WO2001072777A2 Human transcription factors |
| 10/04/2001 | WO2001072752A2 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS |
| 10/04/2001 | WO2001072717A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 10/04/2001 | WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 10/04/2001 | WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors |
| 10/04/2001 | WO2001019361A3 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 10/04/2001 | WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/04/2001 | WO2000032634A9 Humanized antibodies to gamma-interferon |
| 10/04/2001 | US20010027196 Adenosine receptor ligands and their use in the treatment of disease |
| 10/04/2001 | EP1137661A1 Procollagen c-proteinase inhibitors |
| 10/04/2001 | EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 10/04/2001 | EP1123094A4 Therapeutic compositions (ii) |
| 10/04/2001 | EP0809635B1 Alpha-substituted hydrazides having calpain inhibitory activity |
| 10/04/2001 | CA2404570A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2402735A1 Human transcription factors |
| 10/04/2001 | CA2402472A1 2,3,4,5-tetrahydro-1h-¬1,4|diazepino¬1,7a|indole compounds |
| 10/04/2001 | CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 10/04/2001 | CA2374911A1 G-protein coupled receptors |
| 10/03/2001 | CN1315951A FKBP inhibitors |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 09/27/2001 | WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 09/27/2001 | WO2001070695A1 Pyridine derivatives as inhibitors of p38 |
| 09/27/2001 | WO2001070693A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | WO2001070208A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |